Determining the lasting impact on the developing epigenome by gestational toxic exposures

A pregnant woman’s exposure to a low-dose toxin—too weak to cause immediate poisoning—can alter how her unborn child’s DNA is read, and those changes may persist across generations. Most research on toxic chemicals focuses on mutations, which directly damage the genetic code. This project tackles a far less understood problem: how low-level environmental or pharmaceutical exposures during pregnancy change the epigenome—the system that controls which genes are switched on or off. These changes do not alter the DNA sequence itself, but they can permanently disrupt how cells interpret that sequence. The researchers have created transgenic mice whose cells glow when a gene’s epigenetic status changes, allowing them to track these effects in real time across an animal’s entire lifespan and into its offspring. If successful, this work could reveal why some toxic exposures during pregnancy lead to health problems that only appear in adulthood or in the next generation. That knowledge could eventually inform safer drug guidelines for pregnant women and stricter limits on environmental pollutants. This is fundamental science. It does not promise an immediate practical tool, but it builds the mechanistic understanding needed to predict which exposures pose long-term epigenetic risks—a gap that current toxicity testing largely ignores.